Japan First To Approve Omarigliptin, Lusutrombopag

The latest batch of product approvals in Japan includes the first regulatory clearances worldwide for new molecules from Merck and Shionogi, in a further sign that the country's "drug lag" is a thing of the past.

More from Alimentary/Metabolic

More from Therapy Areas